Elanco Animal Health, Inc. (ELAN) reported Tuesday a net loss of $276 million or $0.56 per share for the fourth quarter, sharply wider than $8 million or $0.02 per share in the prior-year quarter.
Excluding items, adjusted earnings for the quarter was $0.13 per share, compared to $0.14 per share in the year-ago quarter.
Total revenues for the quarter grew 12 percent to $1.14 billion from $1.02 billion in the same quarter last year. Organic constant currency revenue growth was 9 percent.
For the first quarter, the company expects adjusted earnings in a range of $0.33 to $0.36 per share on revenues between $1.280 billion and $1.305 billion, with organic constant currency revenue growth of 4 to 6 percent. Looking ahead to fiscal 2026, the company now projects adjusted earnings in a range of $1.00 to $1.06 per share on revenues between $4.95 billion and $5.02 billion, with organic constant currency revenue growth of 4 to 6 percent.
In Tuesday's pre-market trading, ELAN is trading on the NYSE at $24.46, down $0.29 or 1.15 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.